Literature DB >> 2579187

Location of variable and conserved epitopes among the multiple serotypes of streptococcal M protein.

K F Jones, B N Manjula, K H Johnston, S K Hollingshead, J R Scott, V A Fischetti.   

Abstract

In studies primarily confined to the amino-terminal region of the fibrillar group A streptococcal M protein, only limited immunological crossreactions have been observed among M serotypes. In this investigation, two monoclonal antibodies generated against nearly the entire M6 molecule (LysM6) were used to determine the extent of crossreactions among M serotyping strains and to localize their epitopes on the M molecule. Colony blot and immunoblot analyses revealed that an epitope responsible for crossreactions among 5 of the 56 strains of different M serotypes tested is located in the amino-terminal half of the molecule, distal to the cell surface. In contrast, a more common crossreactive epitope, reacting with 20 of the 56 strains, is located near the middle of the M molecule. These studies also reveal that the more conserved determinant, located more proximally to the cell surface, is accessible to the immune system, even on the whole organism, and, thus, may be useful in devising means to protect against infections by multiple group A streptococcal M serotypes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2579187      PMCID: PMC2187582          DOI: 10.1084/jem.161.3.623

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  Current knowledge of type-specific M antigens of group A streptococci.

Authors:  R C LANCEFIELD
Journal:  J Immunol       Date:  1962-09       Impact factor: 5.422

2.  Antigenicity of the M proteins of group A hemolytic streptococci. IV. Cross-reactivity between serotypes.

Authors:  E N Fox; M K Wittner
Journal:  J Immunol       Date:  1968-01       Impact factor: 5.422

3.  Expression of streptococcal M protein in Escherichia coli.

Authors:  J R Scott; V A Fischetti
Journal:  Science       Date:  1983-08-19       Impact factor: 47.728

4.  The complete amino acid sequence of a biologically active 197-residue fragment of M protein isolated from type 5 group A streptococci.

Authors:  B N Manjula; A S Acharya; S M Mische; T Fairwell; V A Fischetti
Journal:  J Biol Chem       Date:  1984-03-25       Impact factor: 5.157

5.  Studies on group A streptococcal M-proteins: purification of type 5 M-protein and comparison of its amino terminal sequence with two immunologically unrelated M-protein molecules.

Authors:  B N Manjula; V A Fischetti
Journal:  J Immunol       Date:  1980-01       Impact factor: 5.422

6.  Streptococcal M protein: alpha-helical coiled-coil structure and arrangement on the cell surface.

Authors:  G N Phillips; P F Flicker; C Cohen; B N Manjula; V A Fischetti
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

7.  Streptococcal M protein extracted by nonionic detergent. II. Analysis of the antibody response to the multiple antigenic determinants of the M-protein molecule.

Authors:  V A Fischetti
Journal:  J Exp Med       Date:  1977-10-01       Impact factor: 14.307

8.  Cross-protective antigens of group A streptococci types 3 and 31 and types 46 and 51.

Authors:  W K Harrell; H Ashworth; R E Davis
Journal:  Infect Immun       Date:  1971-07       Impact factor: 3.441

9.  Electron microscopic studies on streptococci. I. M antigen.

Authors:  J Swanson; K C Hsu; E C Gotschlich
Journal:  J Exp Med       Date:  1969-11-01       Impact factor: 14.307

10.  Cross-reactions among Group A streptococci. I. Precipitin and bactericidal cross-reactions among types 33, 41, 43, 52, and Ross.

Authors:  G G Wiley; P N Bruno
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

View more
  63 in total

1.  Characterization of sarR, a modulator of sar expression in Staphylococcus aureus.

Authors:  A Manna; A L Cheung
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

2.  Immunogenicity of a 26-valent group A streptococcal vaccine.

Authors:  Mary C Hu; Michael A Walls; Steven D Stroop; Mark A Reddish; Bernard Beall; James B Dale
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

3.  Functional and serological analysis of type II immunoglobulin G-binding proteins expressed by pathogenic group A streptococci.

Authors:  R Raeder; R A Otten; L Chamberlin; M D Boyle
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

4.  A novel sortase, SrtC2, from Streptococcus pyogenes anchors a surface protein containing a QVPTGV motif to the cell wall.

Authors:  Timothy C Barnett; Aman R Patel; June R Scott
Journal:  J Bacteriol       Date:  2004-09       Impact factor: 3.490

5.  Domain structure and molecular flexibility of streptococcal M protein in situ probed by limited proteolysis.

Authors:  K M Khandke; T Fairwell; A S Acharya; B N Manjula
Journal:  J Protein Chem       Date:  1990-10

6.  Role of M protein in adherence of group A streptococci.

Authors:  M G Caparon; D S Stephens; A Olsén; J R Scott
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

7.  The amino-terminal region of group A streptococcal M protein determines its molecular state of assembly and function.

Authors:  K M Khandke; T Fairwell; E H Braswell; B N Manjula
Journal:  J Protein Chem       Date:  1991-02

8.  A method for allelic replacement that uses the conjugative transposon Tn916: deletion of the emm6.1 allele in Streptococcus pyogenes JRS4.

Authors:  M Norgren; M G Caparon; J R Scott
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

9.  Mry, a trans-acting positive regulator of the M protein gene of Streptococcus pyogenes with similarity to the receptor proteins of two-component regulatory systems.

Authors:  J Perez-Casal; M G Caparon; J R Scott
Journal:  J Bacteriol       Date:  1991-04       Impact factor: 3.490

10.  M protein mediates streptococcal adhesion to HEp-2 cells.

Authors:  J R Wang; M W Stinson
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.